INNOVENTRIC
Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right heart disease. Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium™ technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising Trillium™ technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies.
INNOVENTRIC
Social Links:
Industry:
Clinical Trials Health Care Medical Device
Founded:
2017-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.innoventric.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
16.9 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Founder
Investors List
Horizon Capital
Horizon Capital investment in Grant - INNOVENTRIC
Official Site Inspections
http://www.innoventric.com
- Host name: 145.223.37.44
- IP address: 145.223.37.44
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
